AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Survey on the Evaluation of Medication Information Leaflets for Organ Transplant Patients

Recruitingn/aAges 18 Years - anyAllUniversität Münster
💬

In plain words

What the trial is, and whether it could suit you

The aim of this study is to collect feedback from organ transplant patients or their caregivers/relatives on the medication information leaflets we've developed, using a questionnaire, and to adjust the content to better meet the specific needs of this unique patient group.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients who have undergone solid organ transplantation (kidney, liver, heart, lung) * Caregivers or family members of organ transplant patients * German-speaking individuals * adult Exclusion Criteria: * Individuals who are not able to provide consent * Non-German-speaking individuals * under 18 years old * Patients who have undergone organ transplantation and are no longer taking immunosuppressants
💊

What it tests

  • Not listed
📍

Where

1 site
Institute of Pharmaceutical and Medicinal Chemistry, Clinical Pharmacy, University of Münster
Münster, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy